BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 6768438)

  • 1. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-modifying drugs for progressive rheumatoid arthritis.
    Bunch TW; O'Duffy JD
    Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
    Tsvetkova ES
    Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P
    Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
    Franchimont P; Heynen G; Hauwaert CH
    J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the order of second-line treatment in rheumatoid arthritis matter?
    Steven MM; Hunter JA; Murdoch RM; Capell HA
    Br Med J (Clin Res Ed); 1982 Jan; 284(6309):79-81. PubMed ID: 6797663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?
    Jellum E; Aaseth J; Munthe E
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761
    [No Abstract]   [Full Text] [Related]  

  • 11. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E; Kåss E
    J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S; Inoue T
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillamine in the treatment of rheumatoid arthritis.
    Camp AV
    J Rheumatol Suppl; 1981; 7():103-6. PubMed ID: 6939871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
    Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
    Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
    [No Abstract]   [Full Text] [Related]  

  • 16. Rheumatoid arthritis V: therapy with remission-inducing agents.
    Gaines LM
    Md State Med J; 1982 Sep; 31(9):49-50. PubMed ID: 6815385
    [No Abstract]   [Full Text] [Related]  

  • 17. Does second-line therapy affect the radiological progression of rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1984 Feb; 43(1):18-23. PubMed ID: 6421253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Disease-modifying" drugs in rheumatoid arthritis.
    Drug Ther Bull; 1985 Dec; 23(26):101-4. PubMed ID: 2866082
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA; McConkey B
    Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.